Abstract:Background: Depressive symptoms and mood disorders are associated with a host of physical conditions. However, it is inconclusive whether depressive symptoms are also associated with cancer onset. The aim of this study was to investigate whether depressive symptoms are associated with cancer incidence in a large population-based sample of men and women. Methods: This study examined data from waves two (HUNT 2, 1995-97) and three (HUNT 3, 2006-08) of the Trøndelag Health Study (HUNT). Depressive symptoms were ascertained using the Hospital Anxiety and Depression Scale (HADS-D ≥ 8), cancer onset was identified via linkage with the Cancer Registry of Norway, death records by the national Cause of Death Register (CDR), and information on lifestyle and demographic factors was self-reported. Cox-proportional hazard regression models were used to test associations. Unadjusted, age-adjusted and multivariable best models accounting for smoking, education, marital status and current employment are presented. Results: Men and women (n = 61,985; 46.0 % men) were followed from baseline over a period of 778,802 person-years. During the 20-year study period, there were 6856 (11.1 %) individuals with incident cancers and 12,480 (20.1 %) deaths (n = 2498 attributed to cancer). For men with depressive symptoms, 505 (15.3 %) developed incident cancer during the follow-up period, whereas among those without depressive symptoms, 3164 (12.5 %) developed incident cancer. Following adjustment for age, depressive symptomology was not significantly associated with risk of overall cancer onset, nor among prostate, colon or melanoma subtypes. Depressive symptoms were associated with an increased risk of bronchus and lung cancer both before (HR 1.90, 95 % CI 1.43-2.50, p ≤0.001) and after adjustment for age (HR 1.38, 95 % CI 1.04-1.80, p = 0.025). However, further adjustment for additional possible confounders explained this association. For women with depressive symptoms, 384 (11.2 %) developed incident cancer during the follow-up period, whereas among those with no depressive symptomology, 2803 (9.3 %) developed incident cancer. After accounting for age, depressive symptomology was not associated with risk of overall cancer onset, nor among breast, colon, lung and bronchus, or melanoma subtypes. Additional analyses evaluating relationship of depression symptom severity and cancer onset did not alter findings for men or women. Limitations: This report is limited by the post-hoc study design and subsequent non-randomised nature. Future prospective studies are required. Conclusion: These results suggest that depressive symptoms are not associated with an increased risk of overall or site-specific cancer onset in these men and women. Given the increased co-occurrence of other medical conditions such as cardiovascular disease, diabetes, stroke and musculoskeletal disorders in people with depression, the role of clinically diagnosed depression and other psychiatric disorders in association with cancer onset necessitates further consideration.

Trends in the prevalence and treatment of comorbid depression among US adults with and without cancer, 2005–2020

Prevalence of major depression, suicidal ideation, and mental health treatment among cancer survivors

Factors associated with depressive symptoms among cancer patients: a nationwide cross-sectional study

Associations of Anxiety and Psychological Distress with Cancer in US Adults: Results from the 2012 National Health Interview Survey

Association between depression and liver function biomarkers among US cancer survivors in NHANES 2005–2020

The prevalence of depression and suicidal ideation among cancer patients in mainland China and its provinces, 1994–2020: A systematic review and meta-analysis of 173 cross-sectional studies

Trends in suicide mortality among cancer survivors in the US, 1975-2020

Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002‐2018

Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment

Influence of depression on breast cancer treatment and survival: A Kentucky population‐based study

Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States

Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients

Mental Health Challenges in Cancer Patients: A Cross-Sectional Analysis of Depression and Anxiety

Temporal trend and subgroup disparities in the prevalence and treatment of those who screen positive for depression in China: A population-based study

Association of depression with all-cause and cancer-specific mortality in older adults with cancer: Systematic review, meta-analysis, and meta-regression

Trends in cancer-related suicide in the United States: a population-based epidemiology study spanning 40 years of data

Prevalence of depressive disorders in breast cancer patients

Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis

Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis

Depressive symptomology and cancer incidence in men and women: Longitudinal evidence from the HUNT study